COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:

Dicyclohexylcarbodiimide (538-75-0)


Study Results


Genetic Toxicology

An overview of Genetic Toxicology Micronucleus Rats study conclusions related to Dicyclohexylcarbodiimide (538-75-0).
Micronucleus - Rats
View
  • Male: Negative
An overview of Genetic Toxicology Micronucleus Mice study conclusions related to Dicyclohexylcarbodiimide (538-75-0).
Micronucleus - Mice
View
  • Male: Weakly Positive
    Female: Weakly Positive
An overview of Genetic Toxicology Bacterial Mutagenicity study conclusions related to Dicyclohexylcarbodiimide (538-75-0).
Bacterial Mutagenicity
View
  • Negative

Citation Information


NTP. Dicyclohexylcarbodiimide (538-75-0). Chemical Effects in Biological Systems (CEBS). Research Triangle Park, NC (USA): National Toxicology Program (NTP). Accessed 2020-07-11. https://manticore.niehs.nih.gov/cebssearch/test_article/538-75-0

Publications


Witt, K.L., Tice, R.R., Shelby, M.D., Chhabra, R.S., and Zeiger, E. Induction of Micronucleated Erythrocytes in Rodents by Diisopropylcarbodiimide and Dicyclohexylcarbodiimide: Dependence on Exposure Protocol. Environ. Molec. Mutag. Vol. 33 (1999) 65-74
GMM-09 Toxicology Studies of Dicyclohexylcarbodiimide (CASRN 538-75-0) in F344/N Rats, B6C3F1 Mice, and Genetically Modified (FVB Tg.AC Hemizygous) Mice and Carcinogenicity Study of Dicyclohexylcarbodiimide in Genetically Modified [B6.129-Trp53tm1Brd (N5) Haploinsufficient] Mice (Dermal Studies)

Study Data


Toxicity and Carcinogenicity Studies


150-Day Evaluation of the Toxicity (C93021B) of Dicyclohexylcarbodiimide (538-75-0) in Tg.AC Mice Exposed via Topical Application
150-Day Evaluation of the Toxicity (C93021B) of Dicyclohexylcarbodiimide (538-75-0) in Tg.AC (FVB/N) Mice Exposed via Topical Application. NTP Special Study
2-Week Evaluation of the Toxicity (C93021) of Dicyclohexylcarbodiimide (538-75-0) in F344/N Rats Exposed via Topical Application
3-Month Evaluation of the Toxicity (C93021) of Dicyclohexylcarbodiimide (538-75-0) in F344 Rats Exposed via Topical Application. NTP Special Study
2-Week Evaluation of the Toxicity (C93021) of Dicyclohexylcarbodiimide (538-75-0) in B6C3F1 Mice Exposed via Topical Application
3-Month Evaluation of the Toxicity (C93021) of Dicyclohexylcarbodiimide (538-75-0) in B6C3F1 Mice Exposed via Topical Application. NTP Special Study
26-Week Evaluation of the Toxicity (C93021C) of Dicyclohexylcarbodiimide (538-75-0) in P53(C57BL/6) Mice Exposed via Topical Application
3-Month Evaluation of the Toxicity (C93021) of Dicyclohexylcarbodiimide (538-75-0) in F344/N Rats Exposed via Topical Application
3-Month Evaluation of the Toxicity (C93021) of Dicyclohexylcarbodiimide (538-75-0) in B6C3F1 Mice Exposed via Topical Application

Genetic Toxicology Studies


Genetic Toxicity Evaluation of Dicyclohexylcarbodiimide (538-75-0) in Micronucleus Study A45449 in F344 Rats
Genetic Toxicity Evaluation of Dicyclohexylcarbodiimide (538-75-0) in Micronucleus Study A63966 in B6C3F1 Mice
Genetic Toxicity Evaluation of Dicyclohexylcarbodiimide in Salmonella/E.coli Mutagenicity Test or Ames Test. Study A46724
Summary Data